Skip navigation

Refine by Type

Refine by Keyword

Results 1 - 10 of 34 for bortezomib
  1. Bortezomib is used to treat people with multiple myeloma (a type of cancer of the bone marrow) ... been treated with at least one other medication. Bortezomib is also used to treat people with mantle ...
  2. Myeloma (Leukemia & Lymphoma Society) - PDF  
    ... other drugs, including carfilzomib is under clinical investigation. Bortezomib (Velcade®). This drug, given intravenously (IV) or subcutaneously ( ... Treatments with novel agents include { { The proteasome inhibitor bortezomib (Velcade), plus liposomal doxorubicin (Doxil®) { { Velcade as a ...
  3. ... the immune system) who have been treated with bortezomib (Velcade) and at least one other medication. Lenalidomide ...
  4. ... least two other medications, including lenalidomide (Revlimid) and bortezomib (Velcade). Pomalidomide is in a class of medications ...
  5. ... Newer drugs such as thalidomide (Thalomid), lenalidomide (Revlimid), bortezomib (Velcade), carfilzomib (Kyprolis), and pomalidomide (Pomalyst) ● Corticosteroids such ...
  6. Mantle Cell Lymphoma (Leukemia & Lymphoma Society) - PDF  
    ... Rituxan®) combinations are used to treat MCL. l Bortezomib (Velcade®) may be used to treat patients who ... developed around the world. Recently, the FDA approved bortezomib (Velcade®) in a combination referred to as VcR- ...
  7. ... with this combination.Talk with your health provider.Bortezomib (Velcade)Bortezomib (Velcade) is used in certain types of cancers. Green tea might interact with bortezomib (Velcade) and decrease its effectiveness for treating certain ...
  8. Facts Spring 2014 (Leukemia & Lymphoma Society) - PDF  
    ... brentuximab vedotin (Adcetris®); and proteasome inhibitors such as bortezomib (Velcade®) and carfilzomib (Kyprolis®). More than 50 individual ... negative relapsed or refractory B cell precursor ALL. Bortezomib (Velcade ® ) is indicated to treat people with myeloma. ...
  9. ... least two prior therapies, including lenalidomide (Revlimid ® ) and bortezomib (Velcade ® ), and whose disease progressed within 60 days ... trial ( CC-4047-MM-007 ) is comparing pomalidomide, bortezomib, and low-dose dexamethasone with bortezomib plus low- ...
  10. ... cells and may prevent the growth of tumors . Bortezomib and carfilzomib are proteasome inhibitors used in the ... or pomalidomide therapy. Targeted therapy with proteasome inhibitors ( bortezomib or carfilzomib ). Chemotherapy . A clinical trial of different ...
previous · 1 · 2 · 3 · 4 · next